ENASIDENIB for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 8 adverse event reports in the FDA FAERS database where ENASIDENIB was used for Neoplasm malignant.

Most Reported Side Effects for ENASIDENIB

Side Effect	Reports	%	Deaths	Hosp.
Death	650	17.6%	650	14
Off label use	213	5.8%	26	35
Fatigue	202	5.5%	5	41
Nausea	197	5.3%	5	40
Acute myeloid leukaemia	163	4.4%	95	43
Hospitalisation	149	4.0%	2	145
Diarrhoea	144	3.9%	1	35
Decreased appetite	122	3.3%	3	35
Platelet count decreased	113	3.1%	3	45
Drug ineffective	108	2.9%	7	16
Differentiation syndrome	102	2.8%	19	66
Pneumonia	91	2.5%	14	69
Pyrexia	90	2.4%	9	71
Asthenia	89	2.4%	2	39
Full blood count decreased	75	2.0%	2	37